Search

Anna DeForest es neuróloga con experiencia en el manejo del dolor y los síntomas para los pacientes con cáncer.

… Neurologist & Supportive Care Physician Job Title Médica adjunta asistente Soy neuróloga con experiencia en manejo del dolor y del síntoma de pacientes con cáncer. Para mí el paciente es un todo, con una historia de vida mucho más extensa y rica que cualquier diagnóstico médico. Mi enfoque de cuidado

… Job Title Senior Research Scientist Degree PhD Email [email protected] Lab Phone 646-888-3286

Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.

… Saturday, September 26, 2015 Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer. In the studies,

Catch up with some of the patients we got to know in 2017.

… Thursday, December 28, 2017 Everyone touched by cancer has a story to tell. We reconnected with just a few of the inspiring people we met in 2017 to see how they’re doing today. Tim Waples It’s been five years since Tim, a special education teacher from Emerson, New Jersey, completed treatment for non-Hodgkin

… The Center for Experimental Therapeutics provides education and training to encourage new investigators to pursue drug discovery and help established investigators improve their work. This includes an annual retreat featuring research presentations by our faculty as well as lectures and discussions with

Our center is focused on developing innovative methods to investigate cancer-immune system interactions at multiple stages of disease progression and inform the design of novel immunotherapeutic interventions.

… Memorial Sloan Kettering’s Center for Tumor-Immune Systems Biology is focused on developing innovative methods to investigate cancer–immune system interactions at multiple stages of disease progression and deploy tools from systems biology to improve our fundamental understanding of tumor-immune interactions

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

… Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Gallbladder

… Job Title Senior Research Assistant

How to reach us by phone, email, and regular mail.

… For more information, call or write to: Virali Shah Program Director School of Radiation Therapy, Box 22 Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, NY 10065 212-639-6835 Email:  [email protected] Carol A. Sweenie Clinical Coordinator School of Radiation Therapy Memorial Sloan Kettering

Paroxysmal nocturnal hemoglobinuria (PNH) is a type of aplastic anemia. PNH is a disease of adulthood, but has been described in children as well. Memorial Sloan Kettering investigators have published one of the world’s largest single center studies of pediatric patients with childhood PNH.

… Paroxysmal nocturnal hemoglobinuria (PNH) is a type of acquired aplastic anemia . It is caused by a mutation that happens in a bone marrow stem cell. In addition to acquired aplastic anemia, children and young adults with PNH may have other complications. For example, red blood cells may break down and